Literature DB >> 17103192

Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension.

Enrico Rosati1, Gianfranco Butera, Eduardo Bossone, Claudio De Felice, Giuseppe Latini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17103192     DOI： 10.1007/s00431-006-0292-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

Review 2.  Monitoring cardiovascular function in infants with chronic lung disease of prematurity.

Authors:  S H Abman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

3.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

4.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

5.  Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  J R Brownlee; R H Beekman; A Rosenthal
Journal:  Pediatr Res       Date:  1988-08       Impact factor: 3.756

6.  Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease.

Authors:  N V Subhedar
Journal:  Acta Paediatr Suppl       Date:  2004-02
  6 in total
  2 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  CPU86017-RS attenuate hypoxia-induced testicular dysfunction in mice by normalizing androgen biosynthesis genes and pro-inflammatory cytokines.

Authors:  Guo-lin Zhang; Feng Yu; De-zai Dai; Yu-si Cheng; Can Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.